|
|
Volumn 28, Issue 6, 2010, Pages 535-536
|
|
Burgeoning stem cell product market lures major suppliers
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH FACTOR;
OXIDIZED CELLULOSE;
REAGENT;
CARDIOVASCULAR DISEASE;
CELL DIFFERENTIATION;
CLINICAL RESEARCH;
DEGENERATIVE DISEASE;
DISEASE MODEL;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SCREENING;
ECTODERM;
EMBRYONIC STEM CELL;
ENDODERM;
HEART MUSCLE CELL;
HUMAN;
IN VITRO STUDY;
LIVER CELL;
MENTAL DISEASE;
MESODERM;
METABOLIC DISORDER;
MONOGENIC DISORDER;
NERVE CELL;
NEURAL STEM CELL;
NONHUMAN;
NOTE;
PANCREAS ISLET CELL;
PLURIPOTENT STEM CELL;
PREDICTION;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
ANIMALS;
CELL DIFFERENTIATION;
COOPERATIVE BEHAVIOR;
DRUG DISCOVERY;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
EMBRYONIC STEM CELLS;
HUMANS;
MARKETING;
MICE;
MYOCYTES, CARDIAC;
REGENERATIVE MEDICINE;
|
|
EID: 77953244293
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0610-535 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
